{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:51:36Z","timestamp":1768387896880,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["N66001-21-C-4014"],"award-info":[{"award-number":["N66001-21-C-4014"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017443","name":"Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense","doi-asserted-by":"publisher","award":["HR0011-21-9-0001"],"award-info":[{"award-number":["HR0011-21-9-0001"]}],"id":[{"id":"10.13039\/100017443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017443","name":"Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense","doi-asserted-by":"publisher","award":["HR0011-21-9-0001"],"award-info":[{"award-number":["HR0011-21-9-0001"]}],"id":[{"id":"10.13039\/100017443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017443","name":"Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense","doi-asserted-by":"publisher","award":["HR0011-21-9-0001"],"award-info":[{"award-number":["HR0011-21-9-0001"]}],"id":[{"id":"10.13039\/100017443","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute","award":["T32CA009171"],"award-info":[{"award-number":["T32CA009171"]}]},{"name":"NIH\/NIAID Collaborative Influenza Vaccine Innovation Centers","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01329-0","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:24:29Z","timestamp":1765607069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel enzymatic DNA produced from a text file achieves comparable immune responses as plasmid vaccine"],"prefix":"10.1038","volume":"11","author":[{"given":"James","family":"Fuller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Kvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Creton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Tursi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Blatney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Godron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winston","family":"Timp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weston","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah H.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"1329_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202200510","volume":"24","author":"J Ashley","year":"2023","unstructured":"Ashley, J., Potts, I. M. & Olorunniji, F. J. Applications of terminal deoxynucleotidyl transferase enzyme in biotechnology. ChemBioChem 24, e202200510 (2023).","journal-title":"ChemBioChem"},{"key":"1329_CR2","first-page":"14","volume":"37","author":"CA Challener","year":"2024","unstructured":"Challener, C. A. Synthetic DNA as an alternative to plasmids. BioPharm. Int. 37, 14\u201317 (2024).","journal-title":"BioPharm. Int."},{"key":"1329_CR3","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.drudis.2020.09.040","volume":"25","author":"J Ohlson","year":"2020","unstructured":"Ohlson, J. Plasmid manufacture is the bottleneck of the genetic medicine revolution. Drug Discov. Today 25, 1891\u20131893 (2020).","journal-title":"Drug Discov. Today"},{"key":"1329_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-022-02402-5","volume":"41","author":"A Conforti","year":"2022","unstructured":"Conforti, A. et al. Linear DNA amplicons as a novel cancer vaccine strategy. J. Exp. Clin. Cancer Res. 41, 195 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1329_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1089\/hum.2007.009","volume":"18","author":"A Vilalta","year":"2007","unstructured":"Vilalta, A. et al. Vaccination with polymerase chain reaction-generated linear expression cassettes protects mice against lethal influenza A challenge. Hum. Gene Ther. 18, 763\u2013771 (2007).","journal-title":"Hum. Gene Ther."},{"key":"1329_CR6","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1016\/j.vaccine.2012.02.071","volume":"30","author":"X Shen","year":"2012","unstructured":"Shen, X. et al. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model. Vaccine 30, 6946\u20136954 (2012).","journal-title":"Vaccine"},{"key":"1329_CR7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2003.09.051","volume":"22","author":"S Moreno","year":"2004","unstructured":"Moreno, S. et al. DNA immunisation with minimalistic expression constructs. Vaccine 22, 1709\u20131716 (2004).","journal-title":"Vaccine"},{"key":"1329_CR8","doi-asserted-by":"publisher","unstructured":"Hughes, R. A. & Ellington, A. D. Synthetic DNA synthesis and assembly: putting the synthetic in synthetic biology. Cold Spring Harb. Perspect. Biol. 9 https:\/\/doi.org\/10.1101\/cshperspect.a023812 (2017).","DOI":"10.1101\/cshperspect.a023812"},{"key":"1329_CR9","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.omtn.2022.08.021","volume":"29","author":"W de Mey","year":"2022","unstructured":"de Mey, W. et al. A synthetic DNA template for fast manufacturing of versatile single epitope mRNA. Mol. Ther. Nucleic Acids 29, 943\u2013954 (2022).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1329_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2013.54","volume":"2","author":"A Hekele","year":"2013","unstructured":"Hekele, A. et al. Rapidly produced SAM\u00ae vaccine against H7N9 influenza is immunogenic in mice. Emerg. Microbes Infect. 2, 1\u20137 (2013).","journal-title":"Emerg. Microbes Infect."},{"key":"1329_CR11","doi-asserted-by":"publisher","first-page":"185ra168","DOI":"10.1126\/scitranslmed.3006368","volume":"5","author":"PR Dormitzer","year":"2013","unstructured":"Dormitzer, P. R. et al. Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci. Transl. Med. 5, 185ra168\u2013185ra168 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1329_CR12","doi-asserted-by":"publisher","unstructured":"Simmons, B. L., McDonald, N. D. & Robinett, N. G. Assessment of enzymatically synthesized DNA for gene assembly. Front. Bioeng. Biotechnol. 11 https:\/\/doi.org\/10.3389\/fbioe.2023.1208784 (2023).","DOI":"10.3389\/fbioe.2023.1208784"},{"key":"1329_CR13","doi-asserted-by":"publisher","first-page":"17332","DOI":"10.1073\/pnas.0508809102","volume":"102","author":"CA Hutchison","year":"2005","unstructured":"Hutchison, C. A., Smith, H. O., Pfannkoch, C. & Venter, J. C. Cell-free cloning using \u03c629 DNA polymerase. Proc. Natl. Acad. Sci. USA 102, 17332\u201317336 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1329_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1101\/gr.180501","volume":"11","author":"FB Dean","year":"2001","unstructured":"Dean, F. B., Nelson, J. R., Giesler, T. L. & Lasken, R. S. Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res. 11, 1095\u20131099 (2001).","journal-title":"Genome Res."},{"key":"1329_CR15","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4161\/hv.4.6.6177","volume":"4","author":"F Kendirgi","year":"2008","unstructured":"Kendirgi, F. et al. Novel linear DNA vaccines induce protective immune responses against lethal infection with influenza virus type A\/H5N1. Hum. Vaccines 4, 410\u2013419 (2008).","journal-title":"Hum. Vaccines"},{"key":"1329_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200835","volume":"32","author":"JF de Graaf","year":"2024","unstructured":"de Graaf, J. F. et al. Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer. Mol. Ther. Oncol. 32, 200835 (2024).","journal-title":"Mol. Ther. Oncol."},{"key":"1329_CR17","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2015.1022008","volume":"11","author":"VL Scott","year":"2015","unstructured":"Scott, V. L. et al. Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice. Hum. Vaccine Immunother. 11, 1972\u20131982 (2015).","journal-title":"Hum. Vaccine Immunother."},{"key":"1329_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/gt.2014.37","volume":"21","author":"AA Walters","year":"2014","unstructured":"Walters, A. A. et al. Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines. Gene Ther. 21, 645\u2013652 (2014).","journal-title":"Gene Ther."},{"key":"1329_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16222-2","volume":"12","author":"Y Masaki","year":"2022","unstructured":"Masaki, Y., Onishi, Y. & Seio, K. Quantification of synthetic errors during chemical synthesis of DNA and its suppression by non-canonical nucleosides. Sci. Rep. 12, 12095 (2022).","journal-title":"Sci. Rep."},{"key":"1329_CR20","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1093\/clinchem\/hvab136","volume":"67","author":"S Filges","year":"2021","unstructured":"Filges, S., Mouhanna, P. & St\u00e5hlberg, A. Digital quantification of chemical oligonucleotide synthesis errors. Clin. Chem. 67, 1384\u20131394 (2021).","journal-title":"Clin. Chem."},{"key":"1329_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tibtech.2011.10.002","volume":"30","author":"S Ma","year":"2012","unstructured":"Ma, S., Saaem, I. & Tian, J. Error correction in gene synthesis technology. Trends Biotechnol. 30, 147\u2013154 (2012).","journal-title":"Trends Biotechnol."},{"key":"1329_CR22","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1093\/nar\/gky303","volume":"46","author":"V Potapov","year":"2018","unstructured":"Potapov, V. et al. A single-molecule sequencing assay for the comprehensive profiling of T4 DNA ligase fidelity and bias during DNA end-joining. Nucleic Acids Res. 46, e79 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1329_CR23","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1021\/acssynbio.8b00333","volume":"7","author":"V Potapov","year":"2018","unstructured":"Potapov, V. et al. Comprehensive profiling of four base overhang ligation fidelity by T4 DNA ligase and application to DNA assembly. ACS Synth. Biol. 7, 2665\u20132674 (2018).","journal-title":"ACS Synth. Biol."},{"key":"1329_CR24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/0264-410X(95)00069-D","volume":"13","author":"TM Pertmer","year":"1995","unstructured":"Pertmer, T. M. et al. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13, 1427\u20131430 (1995).","journal-title":"Vaccine"},{"key":"1329_CR25","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.vaccine.2008.02.033","volume":"26","author":"S Wang","year":"2008","unstructured":"Wang, S. et al. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods. Vaccine 26, 2100\u20132110 (2008).","journal-title":"Vaccine"},{"key":"1329_CR26","doi-asserted-by":"publisher","first-page":"11478","DOI":"10.1073\/pnas.90.24.11478","volume":"90","author":"EF Fynan","year":"1993","unstructured":"Fynan, E. F. et al. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478\u201311482 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1329_CR27","doi-asserted-by":"crossref","unstructured":"Nelson, J. R. et al. TempliPhi, phi29 DNA polymerase based rolling circle amplification of templates for DNA sequencing. Biotechniques 32, 44\u201347 (2002).","DOI":"10.2144\/jun0208"},{"key":"1329_CR28","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1690086\/v1","author":"CC Bradley","year":"2022","unstructured":"Bradley, C. C. et al. RNA polymerase inaccuracy underlies SARS-CoV-2 variants and vaccine heterogeneity. Res. Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-1690086\/v1 (2022).","journal-title":"Res. Sq."},{"key":"1329_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17249-1","volume":"12","author":"TH Chen","year":"2022","unstructured":"Chen, T. H., Potapov, V., Dai, N., Ong, J. L. & Roy, B. N(1)-methyl-pseudouridine is incorporated with higher fidelity than pseudouridine in synthetic RNAs. Sci. Rep. 12, 13017 (2022).","journal-title":"Sci. Rep."},{"key":"1329_CR30","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biotechadv.2017.10.006","volume":"36","author":"HE Wong","year":"2018","unstructured":"Wong, H. E., Huang, C. J. & Zhang, Z. Amino acid misincorporation in recombinant proteins. Biotechnol. Adv. 36, 168\u2013181 (2018).","journal-title":"Biotechnol. Adv."},{"key":"1329_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.copbio.2014.05.003","volume":"30","author":"RP Harris","year":"2014","unstructured":"Harris, R. P. & Kilby, P. M. Amino acid misincorporation in recombinant biopharmaceutical products. Curr. Opin. Biotechnol. 30, 45\u201350 (2014).","journal-title":"Curr. Opin. Biotechnol."},{"key":"1329_CR32","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1089\/hgtb.2015.020","volume":"26","author":"DH Amante","year":"2015","unstructured":"Amante, D. H. et al. Skin transfection patterns and expression kinetics of electroporation-enhanced plasmid delivery using the CELLECTRA-3P, a portable next-generation dermal electroporation device. Hum. Gene Ther. Methods 26, 134\u2013146 (2015).","journal-title":"Hum. Gene Ther. Methods"},{"key":"1329_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56729-6","volume":"16","author":"MP Morrow","year":"2025","unstructured":"Morrow, M. P. et al. DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1\/2 study assessing efficacy, safety, and immunogenicity of INO-3107. Nat. Commun. 16, 1518 (2025).","journal-title":"Nat. Commun."},{"key":"1329_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.virol.2020.08.016","volume":"551","author":"JM Marano","year":"2020","unstructured":"Marano, J. M., Chuong, C. & Weger-Lucarelli, J. Rolling circle amplification: a high fidelity and efficient alternative to plasmid preparation for the rescue of infectious clones. Virology 551, 58\u201363 (2020).","journal-title":"Virology"},{"key":"1329_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1679\/aohc.66.175","volume":"66","author":"R Mizuta","year":"2003","unstructured":"Mizuta, R., Mizuta, M. & Kitamura, D. Atomic force microscopy analysis of rolling circle amplification of plasmid DNA. Arch. Histol. Cytol. 66, 175\u2013181 (2003).","journal-title":"Arch. Histol. Cytol."},{"key":"1329_CR36","doi-asserted-by":"crossref","unstructured":"Sato, M., Ohtsuka, M. & Ohmi, Y. Repeated GenomiPhi, phi29 DNA polymerase-based rolling circle amplification, is useful for generation of large amounts of plasmid DNA. Nucleic Acids Symp. Ser. 48, 147\u2013148 (2004).","DOI":"10.1093\/nass\/48.1.147"},{"key":"1329_CR37","doi-asserted-by":"publisher","unstructured":"Loghin, E. et al. Transient Transfection of Rolling-Circle Amplified DNA in Biomanufacturing-Relevant Mammalian Cell Lines: A Comparison of Transfection Conditions for Optimal Protein Expression. Biotechnol. Appl. Biochem. https:\/\/doi.org\/10.1002\/bab.70100 (2025).","DOI":"10.1002\/bab.70100"},{"key":"1329_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4161\/hv.22908","volume":"9","author":"RJ Cox","year":"2013","unstructured":"Cox, R. J. Correlates of protection to influenza virus, where do we go from here? Hum. Vaccine Immunother. 9, 405\u2013408 (2013).","journal-title":"Hum. Vaccine Immunother."},{"key":"1329_CR39","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41591-024-02894-y","volume":"30","author":"M Yarchoan","year":"2024","unstructured":"Yarchoan, M. et al. Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1\/2 trial. Nat. Med. 30, 1044\u20131053 (2024).","journal-title":"Nat. Med."},{"key":"1329_CR40","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1158\/2326-6066.CIR-18-0283","volume":"7","author":"EK Duperret","year":"2019","unstructured":"Duperret, E. K. et al. A synthetic DNA, multi-neoantigen vaccine drives predominately MHC Class I CD8(+) T-cell responses, impacting tumor challenge. Cancer Immunol. Res. 7, 174\u2013182 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1329_CR41","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","volume":"399","author":"A Khobragade","year":"2022","unstructured":"Khobragade, A. et al. Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India. Lancet 399, 1313\u20131321 (2022).","journal-title":"Lancet"},{"key":"1329_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100689","volume":"31","author":"P Tebas","year":"2021","unstructured":"Tebas, P. et al. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of an open-label, phase 1 clinical trial. EClinicalMedicine 31, 100689 (2021).","journal-title":"EClinicalMedicine"},{"key":"1329_CR43","doi-asserted-by":"publisher","unstructured":"De Rosa, S. C. et al. Robust antibody and cellular responses induced by DNA-only vaccination for HIV. JCI Insight 5 https:\/\/doi.org\/10.1172\/jci.insight.137079 (2020).","DOI":"10.1172\/jci.insight.137079"},{"key":"1329_CR44","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/gt.2009.3","volume":"16","author":"MA Zanta-Boussif","year":"2009","unstructured":"Zanta-Boussif, M. A. et al. Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS. Gene Ther. 16, 605\u2013619 (2009).","journal-title":"Gene Ther."},{"key":"1329_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4049\/jimmunol.173.1.550","volume":"173","author":"S Garg","year":"2004","unstructured":"Garg, S., Oran, A. E., Hon, H. & Jacob, J. The hybrid cytomegalovirus enhancer\/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. J. Immunol. 173, 550\u2013558 (2004).","journal-title":"J. Immunol."},{"key":"1329_CR46","doi-asserted-by":"publisher","first-page":"e11021","DOI":"10.1371\/journal.pone.0011021","volume":"5","author":"PT Loudon","year":"2010","unstructured":"Loudon, P. T. et al. GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates. PLoS ONE 5, e11021 (2010).","journal-title":"PLoS ONE"},{"key":"1329_CR47","unstructured":"How does CCS work. CCS Docs. https:\/\/ccs.how\/how-does-ccs-work."},{"key":"1329_CR48","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1329_CR49","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"1329_CR50","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.21105\/joss.03722","volume":"7","author":"DEL Ajay Khanna","year":"2022","unstructured":"Ajay Khanna, D. E. L. et al. Bam-readcount - rapid generation of basepair-resolution sequence metrics. J. Open Source Softw. 7, 3722 (2022).","journal-title":"J. Open Source Softw."},{"key":"1329_CR51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1586\/14760584.1.3.265","volume":"1","author":"D Chen","year":"2002","unstructured":"Chen, D., Maa, Y. F. & Haynes, J. R. Needle-free epidermal powder immunization. Expert Rev. Vaccines 1, 265\u2013276 (2002).","journal-title":"Expert Rev. Vaccines"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01329-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01329-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:07:41Z","timestamp":1768367261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01329-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01329-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following, which may be considered as potential competing interests: S.C., R.R., and X.G. are employees of DNA Script and have filed patent applications pertaining to aspects of this work. E.K., J.N., and W.G. are employees of GE HealthCare and have filed patent applications pertaining to aspects of this work. D.B.W. is a consultant for and a member of the Scientific Advisory Board for INOVIO Pharmaceuticals. D.H.F. is a consultant for and co-founder of Orlance Inc. Neither Orlance nor INOVIO were involved in the study design, data collection, data analysis, or manuscript preparation. D.B.W. participates in industry collaborations; has received speaking honoraria; and has received fees for consulting, including serving on scientific review committees. Remunerations received by D.B.W. include direct payments and equity\/options. D.B.W. also discloses the following associations with commercial partners: Geneos (consultant\/advisory board), AstraZeneca (advisory board, speaker), and Pfizer (advisory board). All other authors declare that they have no competing interests related to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}